Execs Should Monitor Advocacy Group Concerns, Media Coverage – Diermeier
This article was originally published in The Gray Sheet
Executive Summary
Medical device executives should stay abreast of advocacy group concerns and media portrayal in order to effectively manage the image of their products, according to Daniel Diermeier, PhD, Northwestern University
You may also be interested in...
Mentor Awaits Breast Implant Approval; Advocacy Groups Fight To Stop FDA
Mentor acknowledges that saline breast implant sales could slow in anticipation of silicone breast implant approval imminently
Grassley Requests FDA Info On Guidant ICD Alerts Following NEJM Article
Senate Finance Committee Chair Chuck Grassley (R-Iowa) is asking FDA for a detailed briefing on the "regulatory history" of Guidant's Ventak Prizm 2 DR ICD and the agency's plans to address medical device safety issues
Digene Uses Pharma DTC/Physician-Sales Model To Drive HPV Test Adoption
Digene is channeling its 65-rep clinician sales force and direct-to-consumer advertising to make DNAwithPap tests the standard of care for cervical cancer screening